Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multifactorial Inheritance | 22 | 2023 | 1190 | 5.240 |
Why?
|
Hyperlipoproteinemia Type II | 15 | 2024 | 373 | 4.930 |
Why?
|
Coronary Artery Disease | 46 | 2024 | 6454 | 4.310 |
Why?
|
Atherosclerosis | 21 | 2024 | 3428 | 2.930 |
Why?
|
Lipoprotein(a) | 8 | 2023 | 425 | 2.890 |
Why?
|
Cholesterol, HDL | 13 | 2023 | 1813 | 2.370 |
Why?
|
Cardiovascular Diseases | 35 | 2024 | 15108 | 2.170 |
Why?
|
Genome-Wide Association Study | 39 | 2024 | 12220 | 1.930 |
Why?
|
Coronary Disease | 14 | 2023 | 6078 | 1.750 |
Why?
|
Hypercholesterolemia | 8 | 2024 | 1149 | 1.720 |
Why?
|
Genetic Predisposition to Disease | 33 | 2024 | 17400 | 1.680 |
Why?
|
Genetic Variation | 14 | 2021 | 6540 | 1.480 |
Why?
|
Hypolipidemic Agents | 5 | 2023 | 604 | 1.410 |
Why?
|
Lipoproteins, HDL | 7 | 2023 | 637 | 1.400 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 11 | 2022 | 3239 | 1.380 |
Why?
|
Cholesterol, LDL | 19 | 2024 | 2354 | 1.180 |
Why?
|
Genome, Human | 8 | 2022 | 4420 | 1.080 |
Why?
|
Biological Specimen Banks | 9 | 2022 | 707 | 1.010 |
Why?
|
Niacin | 2 | 2014 | 116 | 0.900 |
Why?
|
Penetrance | 3 | 2023 | 380 | 0.890 |
Why?
|
Fluorobenzenes | 2 | 2014 | 184 | 0.840 |
Why?
|
Dyslipidemias | 4 | 2015 | 848 | 0.840 |
Why?
|
Diabetes Mellitus, Type 2 | 17 | 2023 | 11695 | 0.830 |
Why?
|
Risk Factors | 60 | 2024 | 72145 | 0.810 |
Why?
|
Humans | 166 | 2024 | 742088 | 0.740 |
Why?
|
Intra-Abdominal Fat | 2 | 2023 | 591 | 0.740 |
Why?
|
Hyperlipoproteinemia Type I | 1 | 2019 | 7 | 0.730 |
Why?
|
Heterozygote | 6 | 2020 | 2790 | 0.690 |
Why?
|
Myocardial Infarction | 9 | 2023 | 11690 | 0.680 |
Why?
|
Cholesterol | 5 | 2022 | 2895 | 0.660 |
Why?
|
Disease | 3 | 2020 | 681 | 0.660 |
Why?
|
Lipoprotein Lipase | 3 | 2021 | 125 | 0.660 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 552 | 0.660 |
Why?
|
Middle Aged | 66 | 2024 | 213127 | 0.640 |
Why?
|
Receptors, LDL | 3 | 2023 | 475 | 0.630 |
Why?
|
Asymptomatic Diseases | 2 | 2022 | 552 | 0.630 |
Why?
|
Case-Control Studies | 22 | 2022 | 21719 | 0.600 |
Why?
|
Lipids | 9 | 2022 | 3302 | 0.600 |
Why?
|
Genetic Counseling | 1 | 2021 | 600 | 0.590 |
Why?
|
Metabolic Diseases | 3 | 2022 | 657 | 0.570 |
Why?
|
Lipid Metabolism | 5 | 2021 | 1887 | 0.560 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1263 | 0.560 |
Why?
|
Polymorphism, Single Nucleotide | 23 | 2023 | 15494 | 0.550 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 379 | 0.540 |
Why?
|
Male | 74 | 2024 | 349538 | 0.530 |
Why?
|
Apolipoprotein B-100 | 1 | 2016 | 148 | 0.530 |
Why?
|
Drug Utilization | 1 | 2022 | 1181 | 0.530 |
Why?
|
Heptanoic Acids | 2 | 2015 | 343 | 0.530 |
Why?
|
Pravastatin | 2 | 2015 | 395 | 0.530 |
Why?
|
Obesity | 13 | 2023 | 12705 | 0.520 |
Why?
|
Aged | 41 | 2023 | 162944 | 0.510 |
Why?
|
Female | 74 | 2024 | 379592 | 0.510 |
Why?
|
Propionates | 1 | 2015 | 168 | 0.500 |
Why?
|
Resistin | 1 | 2015 | 170 | 0.490 |
Why?
|
Sulfonamides | 2 | 2014 | 1932 | 0.490 |
Why?
|
Cholesterol Ester Transfer Proteins | 2 | 2017 | 111 | 0.490 |
Why?
|
Fenofibrate | 1 | 2014 | 88 | 0.480 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1073 | 0.480 |
Why?
|
DNA | 4 | 2023 | 7289 | 0.470 |
Why?
|
Triglycerides | 8 | 2019 | 2450 | 0.470 |
Why?
|
Proprotein Convertases | 1 | 2014 | 95 | 0.470 |
Why?
|
Genetic Testing | 6 | 2022 | 3439 | 0.470 |
Why?
|
PPAR alpha | 1 | 2015 | 196 | 0.470 |
Why?
|
Benzodiazepines | 1 | 2020 | 1101 | 0.470 |
Why?
|
Acute Coronary Syndrome | 4 | 2022 | 2337 | 0.460 |
Why?
|
Apolipoproteins B | 3 | 2023 | 373 | 0.460 |
Why?
|
Liver Cirrhosis | 2 | 2020 | 1864 | 0.460 |
Why?
|
Death, Sudden, Cardiac | 3 | 2022 | 1541 | 0.450 |
Why?
|
Genomics | 5 | 2022 | 5692 | 0.450 |
Why?
|
Risk Assessment | 18 | 2023 | 23320 | 0.440 |
Why?
|
Atrial Fibrillation | 5 | 2022 | 5019 | 0.440 |
Why?
|
Pyrimidines | 2 | 2014 | 2933 | 0.410 |
Why?
|
Hemorrhage | 2 | 2021 | 3461 | 0.410 |
Why?
|
Thrombocytopenia | 1 | 2019 | 1171 | 0.400 |
Why?
|
Phenotype | 19 | 2023 | 16331 | 0.400 |
Why?
|
Pyrroles | 2 | 2015 | 1143 | 0.390 |
Why?
|
Body Weight | 2 | 2019 | 4664 | 0.380 |
Why?
|
Foam Cells | 1 | 2011 | 71 | 0.380 |
Why?
|
Heart Failure | 4 | 2022 | 10856 | 0.350 |
Why?
|
Myocarditis | 3 | 2022 | 770 | 0.350 |
Why?
|
Triazoles | 1 | 2015 | 907 | 0.350 |
Why?
|
Biological Transport | 3 | 2011 | 2119 | 0.340 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 3067 | 0.330 |
Why?
|
Aspirin | 1 | 2021 | 3278 | 0.330 |
Why?
|
Holistic Health | 1 | 2008 | 47 | 0.330 |
Why?
|
Adult | 33 | 2024 | 213712 | 0.330 |
Why?
|
Health Status Disparities | 1 | 2020 | 1794 | 0.320 |
Why?
|
Hypertension | 5 | 2023 | 8455 | 0.320 |
Why?
|
Macrophages | 3 | 2013 | 5655 | 0.320 |
Why?
|
Mutation | 9 | 2023 | 29717 | 0.320 |
Why?
|
Anticholesteremic Agents | 2 | 2020 | 979 | 0.320 |
Why?
|
Body Mass Index | 9 | 2023 | 12695 | 0.320 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7901 | 0.310 |
Why?
|
Primary Prevention | 5 | 2022 | 1166 | 0.310 |
Why?
|
Stroke | 8 | 2023 | 9963 | 0.310 |
Why?
|
Genetics, Medical | 2 | 2021 | 337 | 0.310 |
Why?
|
Odds Ratio | 6 | 2020 | 9846 | 0.300 |
Why?
|
Adiposity | 5 | 2023 | 1806 | 0.300 |
Why?
|
Leptin | 1 | 2015 | 1593 | 0.290 |
Why?
|
Secondary Prevention | 3 | 2023 | 1520 | 0.290 |
Why?
|
Mendelian Randomization Analysis | 6 | 2023 | 963 | 0.290 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 882 | 0.290 |
Why?
|
Genetics, Population | 3 | 2021 | 933 | 0.290 |
Why?
|
Life Style | 2 | 2022 | 3824 | 0.280 |
Why?
|
Fasting | 1 | 2012 | 1589 | 0.280 |
Why?
|
Terminally Ill | 1 | 2008 | 238 | 0.280 |
Why?
|
Heart Diseases | 2 | 2021 | 2789 | 0.280 |
Why?
|
Genotype | 9 | 2023 | 12946 | 0.270 |
Why?
|
Thrombolytic Therapy | 1 | 2015 | 2161 | 0.270 |
Why?
|
Eating | 1 | 2012 | 1535 | 0.270 |
Why?
|
Incidence | 9 | 2024 | 20928 | 0.270 |
Why?
|
Waist-Hip Ratio | 2 | 2017 | 517 | 0.270 |
Why?
|
Cohort Studies | 14 | 2024 | 40450 | 0.250 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 24913 | 0.240 |
Why?
|
Obesity, Abdominal | 2 | 2017 | 361 | 0.230 |
Why?
|
Lipoproteins | 2 | 2020 | 876 | 0.230 |
Why?
|
Prospective Studies | 10 | 2024 | 53187 | 0.230 |
Why?
|
Hospitalization | 2 | 2020 | 10232 | 0.220 |
Why?
|
Founder Effect | 1 | 2023 | 190 | 0.220 |
Why?
|
Mutation, Missense | 3 | 2021 | 2556 | 0.220 |
Why?
|
Cholecystitis | 1 | 2023 | 182 | 0.210 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4328 | 0.210 |
Why?
|
Bangladesh | 2 | 2023 | 687 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Adipose Tissue | 3 | 2023 | 3278 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
Nutrition Therapy | 1 | 2023 | 96 | 0.210 |
Why?
|
Disease Management | 3 | 2022 | 2450 | 0.210 |
Why?
|
Electronic Health Records | 4 | 2022 | 4440 | 0.200 |
Why?
|
Cholelithiasis | 1 | 2023 | 411 | 0.200 |
Why?
|
Alzheimer Disease | 1 | 2022 | 7988 | 0.200 |
Why?
|
Eye Hemorrhage | 1 | 2021 | 19 | 0.200 |
Why?
|
Nitric Oxide | 2 | 2022 | 2128 | 0.200 |
Why?
|
Drug Discovery | 1 | 2009 | 1057 | 0.190 |
Why?
|
American Heart Association | 5 | 2024 | 1055 | 0.190 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 161 | 0.190 |
Why?
|
Coronary Vessels | 5 | 2024 | 3099 | 0.190 |
Why?
|
Atlases as Topic | 1 | 2022 | 237 | 0.190 |
Why?
|
Primary Health Care | 1 | 2017 | 4551 | 0.180 |
Why?
|
Semen | 1 | 2022 | 316 | 0.180 |
Why?
|
Heredity | 1 | 2020 | 154 | 0.180 |
Why?
|
Scotland | 1 | 2020 | 155 | 0.180 |
Why?
|
Primates | 1 | 2022 | 543 | 0.180 |
Why?
|
Factor XI | 1 | 2019 | 26 | 0.180 |
Why?
|
Hemoptysis | 1 | 2021 | 155 | 0.180 |
Why?
|
Blood Pressure | 6 | 2023 | 8541 | 0.170 |
Why?
|
Adipose Tissue, White | 1 | 2022 | 345 | 0.170 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12344 | 0.170 |
Why?
|
Immunization, Secondary | 1 | 2021 | 340 | 0.170 |
Why?
|
Photoplethysmography | 1 | 2019 | 56 | 0.170 |
Why?
|
Metagenomics | 1 | 2022 | 430 | 0.170 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 391 | 0.170 |
Why?
|
Chromosome Mapping | 3 | 2022 | 4742 | 0.170 |
Why?
|
Calcium | 5 | 2024 | 5753 | 0.170 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4801 | 0.160 |
Why?
|
Linkage Disequilibrium | 5 | 2022 | 1995 | 0.160 |
Why?
|
Hypertriglyceridemia | 1 | 2021 | 293 | 0.160 |
Why?
|
Open Reading Frames | 1 | 2021 | 810 | 0.160 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 142 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2021 | 325 | 0.160 |
Why?
|
India | 2 | 2023 | 2187 | 0.150 |
Why?
|
Oxidoreductases | 1 | 2020 | 424 | 0.150 |
Why?
|
Insulin Resistance | 3 | 2022 | 3861 | 0.150 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1780 | 0.150 |
Why?
|
Sweden | 1 | 2020 | 1343 | 0.150 |
Why?
|
Double-Blind Method | 3 | 2017 | 12017 | 0.150 |
Why?
|
Angiopoietins | 1 | 2017 | 80 | 0.140 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 102 | 0.140 |
Why?
|
Oligonucleotides | 1 | 2019 | 572 | 0.140 |
Why?
|
Blood Proteins | 1 | 2021 | 1122 | 0.140 |
Why?
|
Risk | 2 | 2020 | 9679 | 0.140 |
Why?
|
Brain Ischemia | 2 | 2021 | 3258 | 0.140 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1679 | 0.140 |
Why?
|
Fingers | 1 | 2019 | 514 | 0.140 |
Why?
|
Cardiovascular System | 1 | 2023 | 827 | 0.140 |
Why?
|
Body Height | 1 | 2022 | 1574 | 0.140 |
Why?
|
Myocardial Ischemia | 2 | 2019 | 2145 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2536 | 0.140 |
Why?
|
Blood Glucose | 5 | 2022 | 6249 | 0.130 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 204 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 313 | 0.130 |
Why?
|
Students, Medical | 1 | 2008 | 1858 | 0.130 |
Why?
|
Sequence Analysis | 1 | 2016 | 256 | 0.130 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2016 | 179 | 0.130 |
Why?
|
Patient Care | 1 | 2021 | 639 | 0.130 |
Why?
|
Pedigree | 2 | 2020 | 4646 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 854 | 0.130 |
Why?
|
Databases, Factual | 3 | 2020 | 7716 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2017 | 689 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2022 | 1221 | 0.120 |
Why?
|
Prevalence | 2 | 2022 | 15194 | 0.120 |
Why?
|
Apolipoprotein A-I | 1 | 2015 | 280 | 0.120 |
Why?
|
Prognosis | 4 | 2020 | 29010 | 0.120 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2699 | 0.120 |
Why?
|
Fatty Liver | 1 | 2020 | 728 | 0.120 |
Why?
|
Apolipoprotein C-III | 1 | 2015 | 202 | 0.120 |
Why?
|
Biofeedback, Psychology | 1 | 2014 | 115 | 0.120 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 995 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 851 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2023 | 1327 | 0.110 |
Why?
|
Gene Frequency | 4 | 2022 | 3587 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1130 | 0.110 |
Why?
|
Pandemics | 3 | 2024 | 8328 | 0.110 |
Why?
|
United States | 10 | 2024 | 69693 | 0.110 |
Why?
|
Qualitative Research | 1 | 2021 | 2680 | 0.110 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39004 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.110 |
Why?
|
Vaccination | 2 | 2022 | 3256 | 0.110 |
Why?
|
Animals | 12 | 2023 | 168561 | 0.100 |
Why?
|
Predictive Value of Tests | 7 | 2023 | 15056 | 0.100 |
Why?
|
Hypoglycemic Agents | 2 | 2017 | 2866 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1790 | 0.100 |
Why?
|
Young Adult | 6 | 2024 | 56350 | 0.100 |
Why?
|
Nanoparticles | 1 | 2023 | 1902 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 3957 | 0.100 |
Why?
|
Recurrence | 2 | 2015 | 8333 | 0.100 |
Why?
|
Simvastatin | 1 | 2013 | 360 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19862 | 0.090 |
Why?
|
Chronic Disease | 2 | 2024 | 9144 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3862 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2011 | 287 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3266 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1237 | 0.090 |
Why?
|
Mental Health | 2 | 2022 | 2997 | 0.090 |
Why?
|
Family | 1 | 2021 | 3144 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 820 | 0.090 |
Why?
|
Constipation | 1 | 2014 | 546 | 0.090 |
Why?
|
Wine | 1 | 2010 | 165 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2195 | 0.090 |
Why?
|
Time Factors | 3 | 2020 | 40054 | 0.090 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.080 |
Why?
|
Placebos | 1 | 2013 | 1677 | 0.080 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2010 | 264 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2017 | 1155 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2011 | 462 | 0.080 |
Why?
|
Holocaust | 1 | 2008 | 34 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2501 | 0.080 |
Why?
|
Behavior Therapy | 1 | 2014 | 866 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4214 | 0.080 |
Why?
|
Databases, Genetic | 3 | 2021 | 1780 | 0.080 |
Why?
|
Hyperemia | 1 | 2010 | 224 | 0.080 |
Why?
|
Mice | 5 | 2022 | 81045 | 0.080 |
Why?
|
Famous Persons | 1 | 2008 | 108 | 0.080 |
Why?
|
Thiazolidinediones | 1 | 2011 | 476 | 0.080 |
Why?
|
Homozygote | 2 | 2023 | 1777 | 0.070 |
Why?
|
Troponin T | 2 | 2023 | 749 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18355 | 0.070 |
Why?
|
Flavonoids | 1 | 2010 | 443 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1184 | 0.070 |
Why?
|
Narration | 1 | 2008 | 210 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2023 | 1573 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7770 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8077 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2011 | 952 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10372 | 0.070 |
Why?
|
Blood Pressure Determination | 1 | 2010 | 632 | 0.070 |
Why?
|
Phenols | 1 | 2010 | 501 | 0.070 |
Why?
|
Patient Compliance | 1 | 2016 | 2680 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3585 | 0.070 |
Why?
|
Child | 5 | 2024 | 77478 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57683 | 0.070 |
Why?
|
Mass Screening | 2 | 2022 | 5238 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7276 | 0.070 |
Why?
|
Social Dominance | 1 | 2005 | 38 | 0.070 |
Why?
|
Coffee | 1 | 2010 | 578 | 0.070 |
Why?
|
Survival Rate | 2 | 2020 | 12773 | 0.060 |
Why?
|
Epigenomics | 2 | 2023 | 902 | 0.060 |
Why?
|
Veterans | 1 | 2018 | 2513 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3766 | 0.060 |
Why?
|
Beverages | 1 | 2010 | 820 | 0.060 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2010 | 578 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6483 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2183 | 0.060 |
Why?
|
Empathy | 1 | 2008 | 472 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2853 | 0.060 |
Why?
|
Logistic Models | 3 | 2017 | 13403 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2014 | 62966 | 0.060 |
Why?
|
Parents | 1 | 2017 | 3387 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15530 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13921 | 0.060 |
Why?
|
Proteins | 1 | 2018 | 6096 | 0.050 |
Why?
|
Pakistan | 1 | 2023 | 296 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5724 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6575 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 9941 | 0.050 |
Why?
|
Liver | 3 | 2023 | 7470 | 0.050 |
Why?
|
Arabs | 1 | 2023 | 177 | 0.050 |
Why?
|
Genetic Pleiotropy | 1 | 2022 | 182 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20086 | 0.050 |
Why?
|
Coronary Angiography | 2 | 2023 | 4567 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2572 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1912 | 0.050 |
Why?
|
Sitosterols | 1 | 2020 | 9 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2024 | 527 | 0.050 |
Why?
|
Population Groups | 1 | 2021 | 208 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6754 | 0.050 |
Why?
|
Phytosterols | 1 | 2020 | 65 | 0.050 |
Why?
|
England | 1 | 2021 | 523 | 0.050 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2020 | 65 | 0.050 |
Why?
|
Lipase | 1 | 2022 | 315 | 0.050 |
Why?
|
Pregnancy | 1 | 2022 | 29087 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 628 | 0.040 |
Why?
|
Factor X | 1 | 2019 | 64 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2020 | 120 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6931 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 7010 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2022 | 592 | 0.040 |
Why?
|
Italy | 1 | 2021 | 828 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2023 | 5095 | 0.040 |
Why?
|
Public Policy | 1 | 2024 | 572 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 527 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 844 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2023 | 488 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 25575 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 206 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2145 | 0.040 |
Why?
|
Macaca mulatta | 1 | 2005 | 2378 | 0.040 |
Why?
|
Chromatin | 2 | 2022 | 2917 | 0.040 |
Why?
|
Apoptosis | 1 | 2014 | 9715 | 0.040 |
Why?
|
Survivors | 1 | 2008 | 2286 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7167 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2021 | 559 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2022 | 676 | 0.040 |
Why?
|
Leukocyte Rolling | 1 | 2017 | 72 | 0.040 |
Why?
|
Echocardiography | 1 | 2010 | 5097 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 85649 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 1020 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2283 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 274 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2017 | 380 | 0.030 |
Why?
|
Haplotypes | 1 | 2022 | 2781 | 0.030 |
Why?
|
Chest Pain | 1 | 2023 | 1113 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3339 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1767 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 531 | 0.030 |
Why?
|
Abdominal Fat | 1 | 2017 | 223 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1656 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2020 | 914 | 0.030 |
Why?
|
Japan | 1 | 2019 | 1360 | 0.030 |
Why?
|
Philadelphia | 1 | 2015 | 263 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1085 | 0.030 |
Why?
|
Attention | 1 | 2005 | 2396 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23387 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 8969 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2023 | 3504 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 962 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2015 | 0.030 |
Why?
|
Up-Regulation | 2 | 2015 | 4211 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 581 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 1792 | 0.030 |
Why?
|
Quality of Life | 1 | 2014 | 12730 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13256 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20774 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2043 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1852 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 14554 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2585 | 0.030 |
Why?
|
Demography | 1 | 2016 | 1650 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2906 | 0.030 |
Why?
|
Gene Silencing | 1 | 2018 | 1538 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2017 | 1363 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19223 | 0.020 |
Why?
|
Decision Making | 1 | 2005 | 3869 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1504 | 0.020 |
Why?
|
Scavenger Receptors, Class B | 1 | 2010 | 81 | 0.020 |
Why?
|
Macular Degeneration | 1 | 2017 | 980 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3728 | 0.020 |
Why?
|
Cardiology | 1 | 2021 | 1658 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3656 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 5385 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21821 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 4983 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3518 | 0.020 |
Why?
|
Cardiac Output, Low | 1 | 2010 | 193 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2015 | 77098 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3493 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4200 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 571 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2187 | 0.020 |
Why?
|
Systole | 1 | 2010 | 956 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2010 | 683 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3335 | 0.020 |
Why?
|
Myocardium | 1 | 2020 | 4775 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2597 | 0.020 |
Why?
|
Electrocardiography | 1 | 2020 | 6440 | 0.020 |
Why?
|
Heart | 1 | 2020 | 4462 | 0.020 |
Why?
|
Diuretics | 1 | 2010 | 591 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2010 | 559 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7873 | 0.020 |
Why?
|
Diet | 1 | 2023 | 7923 | 0.020 |
Why?
|
Societies, Medical | 1 | 2016 | 3740 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2017 | 3455 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1916 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7790 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 5019 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3528 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5304 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2167 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2714 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2005 | 2027 | 0.010 |
Why?
|
Reward | 1 | 2005 | 940 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 13853 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5978 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6294 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35342 | 0.010 |
Why?
|